Moxetumomab Pasudotox-tdfk and Xeljanz XR
Determining the interaction of Moxetumomab Pasudotox-tdfk and Xeljanz XR and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: tofacitinib
Brand name: Xeljanz, Xeljanz XR
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab Pasudotox-tdfk-Xeloda
- Moxetumomab Pasudotox-tdfk-Xelpros
- Moxetumomab Pasudotox-tdfk-Xembify
- Moxetumomab Pasudotox-tdfk-Xenazine
- Moxetumomab Pasudotox-tdfk-Xenical
- Moxetumomab Pasudotox-tdfk-Xenleta
- Xeljanz XR-Moxetumomab pasudotox-tdfk Intravenous
- Xeljanz XR-Moxifloxacin
- Xeljanz XR-Moxifloxacin (Systemic)
- Xeljanz XR-Moxifloxacin Hydrochloride
- Xeljanz XR-Moxifloxacin Injection
- Xeljanz XR-Moxifloxacin Intravenous